Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany
- PMID: 2054785
Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany
Abstract
Sixty-one xeroderma pigmentosum (XP) patients living in the Federal Republic of Germany were investigated. Clinical symptoms were correlated with DNA repair parameters measured in fibroblasts grown from skin biopsies. Classification according to the international complementation groups revealed that of the 61 patients 3 belonged to group A, 26 to group C, 16 to group D, 3 to group E, and 2 to group F; 11 were of the XP variant type. A striking clinical aspect was the frequency of histogenetically different skin tumors varying from one XP complementation group to the other: squamous and basal cell carcinomas predominated in XP group C; lentigo maligna melanomas were most frequent in group D; basal cell carcinomas occurred preferentially in group E and XP variants. Three DNA repair parameters were determined for 46 fibroblast strains: colony-forming ability (D0); DNA repair synthesis (G0); and DNA-incising capacity (E0). Dose-response experiments with up to 13 dose levels were performed throughout to achieve sufficient experimental accuracy. DNA-damaging treatments included UV light, the "UV-like" carcinogen N-acetoxy-2-acetylaminofluorene, and the alkylating carcinogens methyl methanesulfonate and N-methyl-N-nitrosourea. Comparison of clinical signs and repair data was made on the basis of D0, G0, and E0 values of both individual cell strains and weighted means of XP complementation groups. Despite considerable clinical and biochemical heterogeneity within complementation groups distinctive features emerged. In general, D0, G0, and E0 values of all XP strains investigated, including XP variants, were found to be reduced upon treatment with UV light or N-acetoxy-2-acetylaminofluorene. After treatment with UV light or N-acetoxy-2-acetylaminofluorene, cell strains in which DNA-incising capacity was reduced also showed a similar reduction in both colony-forming ability and DNA repair synthesis. Consequently, the weighted mean D0, G0, and E0 values of XP complementation groups and XP variants correlated with each other. Furthermore, the onset of both early dermatological symptoms of XP and tumor growth correlated with the extent of DNA repair defects. Of 45 XP fibroblast strains checked for colony-forming ability after treatment with methyl methanesulfonate only 3 cell strains from group D were found to be more sensitive than normal controls, suggesting that overall repair in XP strains was equal to that in controls. Weighted means of DNA repair synthesis of XP complementation groups, however, showed reductions hinting at impaired excision of distinct alkylated bases.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.Photodermatol Photoimmunol Photomed. 1991 Aug;8(4):146-50. Photodermatol Photoimmunol Photomed. 1991. PMID: 1814424
-
Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.Q J Med. 1979 Apr;48(190):179-210. Q J Med. 1979. PMID: 504548
-
Xeroderma pigmentosum patients from Germany: repair capacity of 45 XP fibroblast strains of the Mannheim XP Collection as measured by colony-forming ability and unscheduled DNA synthesis following treatment with methyl methanesulfonate and N-methyl-N-nitrosourea.J Cancer Res Clin Oncol. 1986;112(3):245-57. doi: 10.1007/BF00395919. J Cancer Res Clin Oncol. 1986. PMID: 3782263 Free PMC article.
-
[DNA repair defect in xeroderma pigmentosum].Gan To Kagaku Ryoho. 1989 Mar;16(3 Pt 2):473-80. Gan To Kagaku Ryoho. 1989. PMID: 2650628 Review. Japanese.
-
Xeroderma pigmentosum.Eur J Dermatol. 2003 Jan-Feb;13(1):4-9. Eur J Dermatol. 2003. PMID: 12609773 Review.
Cited by
-
Nucleotide excision repair factor XPC enhances DNA damage-induced apoptosis by downregulating the antiapoptotic short isoform of caspase-2.Cancer Res. 2012 Feb 1;72(3):666-75. doi: 10.1158/0008-5472.CAN-11-2774. Epub 2011 Dec 15. Cancer Res. 2012. PMID: 22174370 Free PMC article.
-
Neurological disease in xeroderma pigmentosum: prospective cohort study of its features and progression.Brain. 2023 Dec 1;146(12):5044-5059. doi: 10.1093/brain/awad266. Brain. 2023. PMID: 38040034 Free PMC article.
-
Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA.EMBO J. 1991 Dec;10(12):3913-21. doi: 10.1002/j.1460-2075.1991.tb04961.x. EMBO J. 1991. PMID: 1935910 Free PMC article.
-
Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.DNA Repair (Amst). 2011 Jul 15;10(7):781-91. doi: 10.1016/j.dnarep.2011.04.026. Epub 2011 May 25. DNA Repair (Amst). 2011. PMID: 21612988 Free PMC article. Review.
-
Expression of mitochondrial genes and DNA-repair-related nuclear genes is altered in xeroderma pigmentosum fibroblasts.J Cancer Res Clin Oncol. 1994;120(8):454-64. doi: 10.1007/BF01191798. J Cancer Res Clin Oncol. 1994. PMID: 8207043 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials